Henrik Watz Selected Research

prednylidene (Pred)

7/2020	Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: results from COSYCONET.
1/2017	Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort.
4/2015	Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory study.
2/2015	Multi-analyte profiling of inflammatory mediators in COPD sputum--the effects of processing.
4/2013	Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henrik Watz Research Topics

Disease

93	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 04/2006
22	Asthma (Bronchial Asthma) 01/2022 - 08/2014
20	Inflammation (Inflammations) 06/2021 - 04/2006
7	Dyspnea (Shortness of Breath) 01/2020 - 04/2008
6	Emphysema 01/2022 - 07/2008
5	Lung Diseases (Lung Disease) 01/2021 - 04/2013
5	Chronic Bronchitis 01/2021 - 08/2015
5	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2020 - 06/2007
4	Eosinophilia 01/2022 - 10/2011
3	Obstructive Lung Diseases (Obstructive Lung Disease) 03/2021 - 07/2010
3	Pneumonia (Pneumonitis) 01/2021 - 01/2014
3	Necrosis 03/2020 - 01/2019
3	Nasopharyngitis 11/2018 - 10/2013
2	Hypersensitivity (Allergy) 01/2022 - 05/2016
2	Obesity 01/2021 - 01/2017
2	Bronchiectasis 10/2020 - 01/2019
2	Mental Disorders (Mental Disorder) 02/2019 - 10/2017
2	Cough 11/2018 - 10/2017
2	Fatigue 01/2016 - 01/2016
2	Airway Obstruction (Choking) 10/2015 - 04/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012 - 10/2009
1	Heart Diseases (Heart Disease) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Proteinuria 11/2021
1	Lung Injury 11/2021
1	Osteoporosis 01/2021
1	Disease Progression 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020

Drug/Important Bio-Agent (IBA)

25	GoldIBA 01/2022 - 04/2008
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2011
15	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 04/2014
13	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 04/2014
9	C-Reactive ProteinIBA 01/2021 - 04/2008
7	Tiotropium Bromide (Spiriva)FDA Link 03/2021 - 10/2014
6	indacaterolIBA 04/2021 - 09/2010
6	Fibrinogen (Factor I)FDA Link 01/2019 - 04/2008
5	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 04/2015
5	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 04/2021 - 06/2016
5	SteroidsIBA 01/2021 - 04/2014
5	prednylidene (Pred)IBA 07/2020 - 04/2013
4	Immunoglobulin E (IgE)IBA 01/2022 - 08/2014
4	AllergensIBA 01/2022 - 05/2016
4	Muscarinic AntagonistsIBA 04/2021 - 12/2014
4	Biological ProductsIBA 03/2021 - 03/2020
4	Fluticasone (Cutivate)FDA LinkGeneric 04/2020 - 09/2010
4	Salmeterol Xinafoate (Serevent)FDA Link 04/2020 - 09/2010
4	Phosphodiesterase 4 InhibitorsIBA 03/2020 - 10/2013
4	RoflumilastIBA 11/2018 - 01/2016
3	SmokeIBA 11/2021 - 07/2008
3	Mometasone Furoate (Nasonex)FDA LinkGeneric 04/2021 - 04/2020
3	tanimilastIBA 01/2021 - 08/2019
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 03/2020 - 10/2013
3	lipoarabinomannan (LAM)IBA 01/2020 - 03/2010
3	aclidinium bromideIBA 01/2019 - 12/2014
3	Carbon MonoxideIBA 01/2019 - 01/2016
3	olodaterolIBA 10/2017 - 04/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2015 - 10/2009
2	AntibodiesIBA 01/2022 - 01/2022
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 10/2015
2	Acetates (Acetic Acid Esters)FDA Link 04/2021 - 01/2021
2	tiotropium-olodaterolIBA 01/2021 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2012
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 04/2008
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2016
2	danirixinIBA 06/2020 - 10/2018
2	Matrix Metalloproteinases (MMPs)IBA 03/2020 - 10/2011
2	ensifentrineIBA 02/2020 - 01/2020
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 02/2020 - 01/2020
2	Leukotriene B4IBA 08/2019 - 01/2015
2	Transfer Factor (Factor, Transfer)IBA 01/2019 - 01/2017
2	GlucocorticoidsIBA 01/2019 - 10/2014
2	CollagenIBA 01/2018 - 08/2008
2	von Willebrand FactorIBA 01/2015 - 03/2014
2	bimosiamoseIBA 04/2013 - 10/2011
2	SelectinsIBA 04/2013 - 10/2011
2	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2011 - 04/2008
1	dupilumabIBA 01/2022
1	VaccinesIBA 01/2022
1	human PRMT2 proteinIBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 11/2021
1	antineoplaston A10 (A 10)IBA 11/2021
1	TroponinIBA 01/2021
1	GSK573719IBA 01/2021
1	vilanterolIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	fluticasone furoate FDA Link 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Volatile Organic CompoundsIBA 01/2021
1	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 12/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2020
1	Interleukin-8B ReceptorsIBA 06/2020
1	CytokinesIBA 03/2020
1	Cholinergic Agents (Cholinergics)IBA 01/2020

Therapy/Procedure

27	Therapeutics 01/2022 - 04/2006
4	Nebulizers and Vaporizers (Inhaler) 03/2021 - 10/2017
1	Palliative Care (Palliative Therapy) 01/2021
1	Biological Therapy 10/2020